A股異動 | 廣宇發展(000537.SZ)兩連板 擬籌劃重大資產置換
格隆匯9月7日丨廣宇發展(000537.SZ)連續兩日漲停,現報5.83元,封單逾224萬手,暫成交745萬元,最新市值108億元。廣宇發展9月5日晚間公佈,公司擬將所持所屬房地產公司及物業公司股權等資產負債與魯能集團有限公司(以下簡稱"魯能集團")、都城偉業集團有限公司(以下簡稱"都城偉業")合計持有的魯能新能源(集團)有限公司(以下簡稱"魯能新能源")100%股權進行資產置換。此次交易公司股票不停牌。此次交易構成關聯交易,預計將構成重大資產重組,交易完成後,公司控股股東及實控人未發生變化。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.